by The blood preparation market size is poised to grow by USD 81.99 billion by 2032 from USD 48.53 billion in 2023, exhibiting a CAGR of 6% during the forecast period 2023-2032.
Key Takeaways
- North America contributed more than 45% of revenue share in 2022.
- Asia Pacific is expected to witness the fastest growth rate in the blood preparation market during the forecast period.
- By product, the whole blood segment held the largest share of the blood preparation market in 2022.
- The blood derivatives segment is expected to grow at a significant compounded annual growth (CAGR) rate during the forecast period.
- By application, the thrombocytosis segment accounted for a larger share in 2022.
- The angina blood vessel complications segment is estimated to grow with a notable CAGR during the study period till 2032.
Precedence Research has conducted a comprehensive market study that provides valuable insights into the performance of the market during the forecast period. The study identifies significant trends that are shaping the growth of the Blood preparation market. In this recently published report, essential dynamics such as drivers, restraints, and opportunities are highlighted for both established market players and emerging participants involved in production and supply.
To begin with, the Blood preparation Market report features an executive summary that offers a concise overview of the marketplace. It outlines the key players and industry categories expected to have an impact on the market in the coming years. The executive summary provides an unbiased summary of the market.
Get a Sample Report: https://www.precedenceresearch.com/sample/3551
Blood Preparation Market Scope
| Report Coverage | Details |
| Growth Rate from 2023 to 2032 | CAGR of 6% |
| Market Size in 2023 | USD 48.53 Billion |
| Market Size by 2032 | USD 81.99 Billion |
| Largest Market | North America |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Segments Covered | By Product, By Antithrombotic and Anticoagulants Type, By Application, and By End User |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Read More: Molecular Biology Enzymes Market Size To Rake USD 58.83 Bn By 2032
The empirical study on the global Blood preparation market primarily focuses on the drivers in subsequent sections. It demonstrates how changing demographics are projected to influence the supply and demand dynamics in the Blood preparation Market. Our market report for the Blood preparation market also delves into the significant rules and regulations that are likely to impact the future growth of this sector. Moreover, in order to comprehend the underlying demand factors, industry experts have provided insights into its fundamental origins.
Blood Preparation Market Players
- AstraZeneca plc
- Baxter International Inc
- Bristol-Myers Squibb Company
- Celgene Corp.
- GlaxoSmithKline PLC
- Leo Pharma A/S
- Pfizer, Inc.
- Portola Pharmaceuticals, Inc.
- Sanofi
- Shandong East Chemical Industry Co.
- Xiamen Hisunny Chemical Co., LTD
Data Sources and Methodology
To gather comprehensive insights on the Global Blood preparation Market, we relied on a range of data sources and followed a well-defined methodology. Our approach involved interactions with industry experts and key stakeholders across the market’s value chain, including management organizations, processing organizations, and analytics service providers.
We followed a rigorous data analysis process to ensure the quality and credibility of our research. The gathered information was carefully evaluated, and relevant quantitative data was subjected to statistical analysis. By employing robust analytical techniques, we were able to derive meaningful insights and present a comprehensive overview of the Global Blood preparation Market.
The most resonating, simple, genuine, and important causes because of which you must decide to buy the Blood preparation market report exclusively from precedence research
- The research report has been meticulously crafted to provide comprehensive knowledge on essential marketing strategies and a holistic understanding of crucial marketing plans spanning the forecasted period from 2023 to 2032.
Key Features of the Report:
- Comprehensive Coverage: The report extensively encompasses a detailed explanation of highly effective analytical marketing methods applicable to companies across all industry sectors.
- Decision-Making Enhancement: It outlines a concise overview of the decision-making process while highlighting key techniques to enhance it, ensuring favorable business outcomes in the future.
- Articulated R&D Approach: The report presents a well-defined approach to conducting research and development (R&D) activities, enabling accurate data acquisition on current and future marketing conditions.
Market Segmentation:
By Product
- Whole blood
- Granulocytes
- Red blood cells
- Plasma
- Platelets
- Blood components
- Leukocyte reduced red blood cells
- Packed red blood cells
- Frozen plasma
- Platelet concentrates
- Cryoprecipitate
- Blood derivatives
By Antithrombotic and Anticoagulants Type
- Platelet aggregation inhibitors
- Glycoprotein inhibitors
- ADP antagonists
- COX inhibitors
- Others
- Fibrinolytics
- Streptokinase
- Tissue plasminogen activator (tPA)
- Urokinase
- Anticoagulants
- Heparins
- Low molecular weight heparin (LMWH)
- Unfractionated heparin
- Ultra-low molecular weight heparin
- Direct thrombin inhibitors
- Vitamin K antagonists
- Direct factor Xa inhibitors
- Heparins
By Application
- Thrombocytosis
- Renal impairment
- Pulmonary embolism
- Angina blood vessel complications
- Others
By End User
- Clinics
- Hospitals
- Diagnostic centers
- Research labs
- Blood banks
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
Reasons to Consider Purchasing the Report:
- Enhance your market research capabilities by accessing this comprehensive and precise report on the global Blood preparation market.
- Gain a thorough understanding of the overall market landscape and be prepared to overcome challenges while ensuring robust growth.
- Benefit from in-depth research and analysis of the latest trends shaping the global Blood preparation market.
- Obtain detailed insights into evolving market trends, current and future technologies, and strategic approaches employed by key players in the global Blood preparation market.
- Receive valuable recommendations and guidance for both new entrants and established players seeking further market expansion.
- Discover not only the cutting-edge technological advancements in the global Blood preparation market but also the strategic plans of industry leaders.
Table of Content
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Blood Preparation Market
5.1. COVID-19 Landscape: Blood Preparation Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Blood Preparation Market, By Product
8.1. Blood Preparation Market Revenue and Volume Forecast, by Product, 2023-2032
8.1.1. Whole blood
8.1.1.1. Market Revenue and Volume Forecast (2020-2032)
8.1.2. Blood components
8.1.2.1. Market Revenue and Volume Forecast (2020-2032)
8.1.3. Blood derivatives
8.1.3.1. Market Revenue and Volume Forecast (2020-2032)
Chapter 9. Global Blood Preparation Market, By Antithrombotic and Anticoagulants Type
9.1. Blood Preparation Market Revenue and Volume Forecast, by Antithrombotic and Anticoagulants Type, 2023-2032
9.1.1. Platelet aggregation inhibitors
9.1.1.1. Market Revenue and Volume Forecast (2020-2032)
9.1.2. Fibrinolytics
9.1.2.1. Market Revenue and Volume Forecast (2020-2032)
9.1.3. Anticoagulants
9.1.3.1. Market Revenue and Volume Forecast (2020-2032)
Chapter 10. Global Blood Preparation Market, By Application
10.1. Blood Preparation Market Revenue and Volume Forecast, by Application, 2023-2032
10.1.1. Thrombocytosis
10.1.1.1. Market Revenue and Volume Forecast (2020-2032)
10.1.2. Renal impairment
10.1.2.1. Market Revenue and Volume Forecast (2020-2032)
10.1.3. Pulmonary embolism
10.1.3.1. Market Revenue and Volume Forecast (2020-2032)
10.1.4. Angina blood vessel complications
10.1.4.1. Market Revenue and Volume Forecast (2020-2032)
10.1.5. Others
10.1.5.1. Market Revenue and Volume Forecast (2020-2032)
Chapter 11. Global Blood Preparation Market, By End User
11.1. Blood Preparation Market Revenue and Volume Forecast, by End User, 2023-2032
11.1.1. Clinics
11.1.1.1. Market Revenue and Volume Forecast (2020-2032)
11.1.2. Hospitals
11.1.2.1. Market Revenue and Volume Forecast (2020-2032)
11.1.3. Diagnostic centers
11.1.3.1. Market Revenue and Volume Forecast (2020-2032)
11.1.4. Research labs
11.1.4.1. Market Revenue and Volume Forecast (2020-2032)
11.1.5. Blood banks
11.1.5.1. Market Revenue and Volume Forecast (2020-2032)
Chapter 12. Global Blood Preparation Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Volume Forecast, by Product (2020-2032)
12.1.2. Market Revenue and Volume Forecast, by Antithrombotic and Anticoagulants Type (2020-2032)
12.1.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.1.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.1.5. U.S.
12.1.5.1. Market Revenue and Volume Forecast, by Product (2020-2032)
12.1.5.2. Market Revenue and Volume Forecast, by Antithrombotic and Anticoagulants Type (2020-2032)
12.1.5.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.1.5.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Volume Forecast, by Product (2020-2032)
12.1.6.2. Market Revenue and Volume Forecast, by Antithrombotic and Anticoagulants Type (2020-2032)
12.1.6.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.1.6.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.2. Europe
12.2.1. Market Revenue and Volume Forecast, by Product (2020-2032)
12.2.2. Market Revenue and Volume Forecast, by Antithrombotic and Anticoagulants Type (2020-2032)
12.2.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.2.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.2.5. UK
12.2.5.1. Market Revenue and Volume Forecast, by Product (2020-2032)
12.2.5.2. Market Revenue and Volume Forecast, by Antithrombotic and Anticoagulants Type (2020-2032)
12.2.5.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.2.5.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.2.6. Germany
12.2.6.1. Market Revenue and Volume Forecast, by Product (2020-2032)
12.2.6.2. Market Revenue and Volume Forecast, by Antithrombotic and Anticoagulants Type (2020-2032)
12.2.6.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.2.6.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.2.7. France
12.2.7.1. Market Revenue and Volume Forecast, by Product (2020-2032)
12.2.7.2. Market Revenue and Volume Forecast, by Antithrombotic and Anticoagulants Type (2020-2032)
12.2.7.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.2.7.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Volume Forecast, by Product (2020-2032)
12.2.8.2. Market Revenue and Volume Forecast, by Antithrombotic and Anticoagulants Type (2020-2032)
12.2.8.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.2.8.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.3. APAC
12.3.1. Market Revenue and Volume Forecast, by Product (2020-2032)
12.3.2. Market Revenue and Volume Forecast, by Antithrombotic and Anticoagulants Type (2020-2032)
12.3.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.3.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.3.5. India
12.3.5.1. Market Revenue and Volume Forecast, by Product (2020-2032)
12.3.5.2. Market Revenue and Volume Forecast, by Antithrombotic and Anticoagulants Type (2020-2032)
12.3.5.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.3.5.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.3.6. China
12.3.6.1. Market Revenue and Volume Forecast, by Product (2020-2032)
12.3.6.2. Market Revenue and Volume Forecast, by Antithrombotic and Anticoagulants Type (2020-2032)
12.3.6.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.3.6.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.3.7. Japan
12.3.7.1. Market Revenue and Volume Forecast, by Product (2020-2032)
12.3.7.2. Market Revenue and Volume Forecast, by Antithrombotic and Anticoagulants Type (2020-2032)
12.3.7.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.3.7.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Volume Forecast, by Product (2020-2032)
12.3.8.2. Market Revenue and Volume Forecast, by Antithrombotic and Anticoagulants Type (2020-2032)
12.3.8.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.3.8.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.4. MEA
12.4.1. Market Revenue and Volume Forecast, by Product (2020-2032)
12.4.2. Market Revenue and Volume Forecast, by Antithrombotic and Anticoagulants Type (2020-2032)
12.4.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.4.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.4.5. GCC
12.4.5.1. Market Revenue and Volume Forecast, by Product (2020-2032)
12.4.5.2. Market Revenue and Volume Forecast, by Antithrombotic and Anticoagulants Type (2020-2032)
12.4.5.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.4.5.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.4.6. North Africa
12.4.6.1. Market Revenue and Volume Forecast, by Product (2020-2032)
12.4.6.2. Market Revenue and Volume Forecast, by Antithrombotic and Anticoagulants Type (2020-2032)
12.4.6.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.4.6.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.4.7. South Africa
12.4.7.1. Market Revenue and Volume Forecast, by Product (2020-2032)
12.4.7.2. Market Revenue and Volume Forecast, by Antithrombotic and Anticoagulants Type (2020-2032)
12.4.7.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.4.7.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Volume Forecast, by Product (2020-2032)
12.4.8.2. Market Revenue and Volume Forecast, by Antithrombotic and Anticoagulants Type (2020-2032)
12.4.8.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.4.8.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.5. Latin America
12.5.1. Market Revenue and Volume Forecast, by Product (2020-2032)
12.5.2. Market Revenue and Volume Forecast, by Antithrombotic and Anticoagulants Type (2020-2032)
12.5.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.5.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.5.5. Brazil
12.5.5.1. Market Revenue and Volume Forecast, by Product (2020-2032)
12.5.5.2. Market Revenue and Volume Forecast, by Antithrombotic and Anticoagulants Type (2020-2032)
12.5.5.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.5.5.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Volume Forecast, by Product (2020-2032)
12.5.6.2. Market Revenue and Volume Forecast, by Antithrombotic and Anticoagulants Type (2020-2032)
12.5.6.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.5.6.4. Market Revenue and Volume Forecast, by End User (2020-2032)
Chapter 13. Company Profiles
13.1. AstraZeneca plc
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Baxter International Inc
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Bristol-Myers Squibb Company
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Celgene Corp.
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. GlaxoSmithKline PLC
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Leo Pharma A/S
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Pfizer, Inc.
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Portola Pharmaceuticals, Inc.
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Sanofi
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Shandong East Chemical Industry Co.
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
Unlocking Market Insights through Data Excellence
The “Precedence Statistics” flexible dashboard is a powerful tool that offers real-time news updates, economic and market forecasts, and customizable reports. It can be configured to support a wide range of analysis styles and strategic planning needs. This tool empowers users to stay informed and make data-driven decisions in various scenarios, making it a valuable asset for businesses and professionals looking to stay ahead in today’s dynamic and data-driven world.
Access our Premium Real Time Data Intelligence Tool, Visit: www.precedencestatistics.com
Precedence Statistics – Empowering Your Data Insights
Contact Us
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
